Navigation Links
ARKRAY, Inc. Long Term Care Division Launches Comprehensive Service Program - Assure(R) Brilliance
Date:1/15/2010

EDINA, Minn., Jan. 15 /PRNewswire/ -- ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, launches the Assure Brilliance Program – a comprehensive service program for Long Term Care facilities and multi-patient use settings.

Assure® brand blood glucose monitoring systems from ARKRAY have been the leading brand of blood glucose meters in Long Term Care for years. ARKRAY has always been committed to providing excellent services to customers and the Assure Brilliance program is the next step in providing truly comprehensive diabetes management help to over-burdened LTC facilities.

Assure Brilliance consists of three main components – service, diabetes program management, and education. ARKRAY is the only blood glucose meter manufacturer with a dedicated LTC sales force. The company provides on-site training for all shifts, convenient customer service hours for LTC facilities, QA/QC guidance, and extensive training materials, videos, and online resources. The focus on diabetes in Long Term Care has allowed ARKARY to develop an expertise in managing diabetes in LTC – knowledge that is passed along to customers, keeping everyone up-to-date on industry best practices. ARKRAY also offers customers multiple CE courses online at no charge and a quarterly newsletter focused on industry hot buttons such as infection control and F-Tags.

Assure Blood Glucose Meters, including the new auto-code Assure® Platinum meter, are backed by the Assure® Brilliance program to help facilities manage complex diabetes care in their facilities. ARKRAY representatives can do consultations to find how LTC facilities may best benefit from the Assure Brilliance Program.

About ARKRAY USA - ARKRAY, the leader in the Long Term Care blood glucose market, has been a pioneer for nearly 50 years in the field of automated analysis from laboratory and point-of-care systems to home use patient self-testing systems. ARKRAY is one of the few diabetes testing companies in the U.S. market today that undertakes in-house each step of the development process to bring products to market. ARKRAY strongly believes in the relentless innovation of medical technology and focused attention to producing the highest quality products. For patients and health care professionals, this means access to cutting-edge, reliable products and customer-focused service.

For more information:

www.assureusa.com or www.arkrayusa.com

SOURCE ARKRAY, Inc.

RELATED LINKS
http://www.assureusa.com
http://www.arkrayusa.com

'/>"/>

SOURCE ARKRAY, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System
2. ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System
3. ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer
4. Strykers Biotech Division Receives FDA Warning Letter
5. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
6. European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK
7. California Cryobank Names Richard Jennings President of FamilyCord Division
8. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
9. Vivakor Divisions Continue to Demonstrate Independent Growth
10. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
11. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):